Larger public sector role sought on biotech

Larger public sector role sought on biotech - PubMed

KIE: Increasing opposition to field tests of genetically altered organisms is causing the biotechnology industry to look to some form of government regulation ...

Larger Public Sector Role Sought on Biotech - Science

Larger Public Sector Role Sought on Biotech: Controversy stirred up by initial field test plans worries industry, triggers demand for broader government action.

Larger public sector role sought on biotech - Document - Gale ...

Gale OneFile includes Larger public sector role sought on biotech by Mark Crawford. Read the beginning or sign in for the full text.

Larger public sector role sought on biotech - DigitalGeorgetown Home

Larger public sector role sought on biotech. Creator. Crawford, Mark. Bibliographic Citation. Science 1986 April 4; 232(4746): 15-16. Permanent Link.

The Future of Biotech - DNI.gov

A drop in the cost of key enabling technologies could spur application of biotech to a wider set of challenges and potentially democratize aspects of biotech ...

A New National Purpose: Leading the Biotech Revolution

Orient to produce high-scale companies and become home to the superstars of the future. Globally, the biotech sector is already worth more than ...

The worsening divergence of biotechnology: the importance of risk ...

Public trust in government institutions is crucial; faith in the government's ability to regulate and monitor new technologies with uncertain ...

Fact Sheet: Biden-Harris Administration's Actions to Advance ...

These critical achievements highlight the Biden-Harris Administration's government-wide approach to advancing the biotechnology and ...

Biotech financing: darkest before the dawn | Nature Biotechnology

a, Venture funding for cell and gene therapy has plummeted in 2024, reflecting clinical, manufacturing and commercial hurdles. b, Companies ...

Government and Academic Positions in Biotechnology - Blog

Government and academic positions offer unique opportunities to shape the future of biotechnology, from influencing policy decisions to ...

Taking Stock of U.S.-China Biotechnology Competition - Asia Society

In September 2022, the White House issued a biotechnology executive order (EO), which accelerates a “whole-of-government approach” to respond to ...

Building the Bioworkforce of the Future | The White House

directs the United States Government to expand training and education opportunities for all Americans in biotechnology and biomanufacturing. Specifically, the ...

Biotech Matters: Public-Private Coordination of Biotechnology | CNAS

As in so many other fields, the U.S. government promotes these advances through grants for research and development and by purchasing finished ...

Biotech IPOs in 2024: Navigating the New Wave of Innovation - Xtalks

This enables the company to raise funds from public investors. Successful biotech IPOs in 2024 have the potential to generate substantial ...

Switch from industry job to government job? : r/biotech - Reddit

Hi all, just wanted to ask if anyone's switched from industry to a government job and what their experience has been.

Multiple Pathways for Legal Pros to Move Into Biotech GC Role

It could be the mission-driven focus of helping patients and moving healthcare forward, or the complex and highly varied legal, regulatory and business ...

National Action Plan for US Leadership in Biotechnology | SCSP

The U.S. Government (USG) has taken a number of important steps to set the course for biotechnology leadership. Yet, China still looms large in ...

Why People in Biotech Move Jobs - Medium

What do you think are the most important drivers behind people moving jobs in the Biotech sector ... public speaking, project management ...

Emerging Roles in Life Sciences & Biotech - Recruitment Entrepreneur

The global biotech market is on track to exceed $3.44 trillion by 2030. In the UK, the biotech sector, known for its robust academic foundation ...

House backs bill restricting China role in US biotech - BioPharma Dive

The legislation would prohibit the federal government from contracting with the five “companies of concern” or any biotech that has a contract ...